Cargando…
Soluble CD163 and TWEAK in early pregnancy gestational diabetes and later glucose intolerance
Gestational diabetes mellitus (GDM) is today universally diagnosed during late pregnancy. Treating hyperglycaemia during pregnancy reduces the risk of complications, the effect of interventions is however limited due to the late diagnosis. It is thus important to identify biomarkers reaching a high...
Autores principales: | Dereke, Jonatan, Nilsson, Jacob, Nilsson, Charlotta, Strevens, Helena, Landin-Olsson, Mona, Hillman, Magnus |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6508637/ https://www.ncbi.nlm.nih.gov/pubmed/31071174 http://dx.doi.org/10.1371/journal.pone.0216728 |
Ejemplares similares
-
Soluble plasma proteins ST2 and CD163 as early biomarkers of nephropathy in Swedish patients with diabetes, 15–34 years of age: a prospective cohort study
por: Samuelsson, My, et al.
Publicado: (2017) -
Plasma Levels of the Interleukin-1-Receptor Antagonist Are Lower in Women with Gestational Diabetes Mellitus and Are Particularly Associated with Postpartum Development of Type 2 Diabetes
por: Katra, Pernilla, et al.
Publicado: (2016) -
Low levels of soluble TWEAK, indicating on-going inflammation, were associated with depression in type 1 diabetes: a cross-sectional study
por: Melin, Eva O., et al.
Publicado: (2020) -
Soluble CD163 was linked to galectin-3, diabetic retinopathy and antidepressants in type 1 diabetes
por: Melin, Eva O, et al.
Publicado: (2018) -
Female sex, high soluble CD163, and low HDL-cholesterol were associated with high galectin-3 binding protein in type 1 diabetes
por: Melin, Eva Olga, et al.
Publicado: (2019)